Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • Cross-Sectoral Health Threats
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2024 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. Cross-Sectoral Health Threats
          3. IMEDS
          4. Post Market Research
          5. RAISE
          6. Real World Data
          7. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2024 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

Major FDA reorganization will heavily impact human foods program - LexBlog

What started as a crisis over the safety and supply of infant formula became a wide-ranging review of FDA’s food programs by the Reagan-Udall Foundation.

Read more

Coverage
  • Read more about Major FDA reorganization will heavily impact human foods program - LexBlog

Chronic-disease Self-management Program in Patients Living With Long-COVID in Puerto Rico

  • Read more about Chronic-disease Self-management Program in Patients Living With Long-COVID in Puerto Rico

Qualifying Biomarkers to Support Rare Disease Regulatory Pathways

  • Read more about Qualifying Biomarkers to Support Rare Disease Regulatory Pathways

Qualifying Biomarkers to Support Rare Disease Regulatory Pathways
Case example: Heparan sulfate in neuronopathic lysosomal storage diseases

Public Workshop: In-Person and Virtual
February 21, 2024 | 10am-4pm (eastern)

RemeGen Co., LTD.

By jpalfreyman on Tue, 01/16/2024 - 12:58
  • Read more about RemeGen Co., LTD.

FDA’s Center for Tobacco Products Publishes Strategic Plan - JD Supra

The Food and Drug Administration’s Center for Tobacco Products (“CTP”) has released a strategic plan intended to guide the Center’s activity for the next five years.

Coverage
  • Read more about FDA’s Center for Tobacco Products Publishes Strategic Plan - JD Supra

To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism

  • Read more about To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism

Mild Water-filtered Infrared-A Whole-body Hyperthermia in Patients With Post-COVID Syndrome (HyPoCo)

  • Read more about Mild Water-filtered Infrared-A Whole-body Hyperthermia in Patients With Post-COVID Syndrome (HyPoCo)

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

  • Read more about Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

The Canadian COVID-19 Prospective Cohort Study

  • Read more about The Canadian COVID-19 Prospective Cohort Study

Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project

  • Read more about Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • Current page 100
  • Page 101
  • Page 102
  • Page 103
  • Page 104
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA